Similar Posts
Ultragenyx CEO talks the company’s path to profitability in developing drugs for rare diseases
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Dr. Emil Kakkis, Ultragenyx founder & CEO, joins ‘Closing Bell Overtime’ to talk drug trials and development, its path to profitability and more.
CVS to close ‘select’ pharmacies in Target stores starting in February
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email CNBC’s Bertha Coombs joins ‘Closing Bell’ to report on the announcement from CVS on their plan to close select pharmacies inside Target locations beginning in February.
We like the Mag 5 but are not fans of Apple or Tesla, says Cantor Fitzgerald’s Eric Johnston
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Eric Johnston, Cantor Fitzgerald head of equity derivatives and cross asset, joins ‘Closing Bell Overtime’ to talk the day’s market action and his investing playbook for 2024.
CNBC PRO Talks: Morningstar’s chief U.S. strategist on stocks to beat the volatility
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Dave Sekera, chief U.S market strategist for Morningstar, joined CNBC’s Julianna Tatelbaum on Wednesday for a frank conversation on the market outlook. 33:50 Wed, Jul 13 20229:16 AM EDT
The Bitcoin ETF wrapper will help investors manage risks, says BlackRock’s Samara Cohen
CNBC’s Bob Pisani with BlackRock’s Samara Cohen, joins ‘Squawk on the Street’ to discuss crypto as the Bitcoin ETFs begin trading today.
Watch CNBC’s full interview with Gabelli Funds’ Tony Bancroft and Crutchfield + Partners’ Dean Crutchfield
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Dean Crutchfield, CEO of the crisis management firm Crutchfield + Partners, and Tony Bancroft, portfolio manager at Gabelli Funds, join ‘Power Lunch’ to discuss the continued market fallout for Boeing following a plane’s parts malfunction. 11:57 Wed, Jan 10 20242:27 PM EST
